Country: যুক্তরাজ্য
ভাষা: ইংরেজি
সূত্র: myHealthbox
ceftriaxone sodium
Midas Pharma GmbH
J01DD04
ceftriaxone sodium
0.596g
Powder for solution for injection
Oral use
Packs size: 10 vials
POM - Prescription Only Medicine
Midas Pharma GmbH
Antibacterials for systemic use, Third generation cephalosporins
It is indicated for the treatment of the following infections in adults and children including term neonates (from birth): • Bacterial Meningitis • Community acquired pneumonia • Hospital acquired pneumonia • Acute otitis media • Intra-abdominal infections • Complicated urinary tract infections (including pyelonephritis) • Infections of bones and joints • Complicated skin and soft tissue infections • Gonorrhoea • Syphilis • Bacterial endocarditis
Authorised
2015-04-02
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT CEFTRIAXONE 500 MG POWDER FOR SOLUTION FOR INJECTION CEFTRIAXONE 2 G POWDER FOR SOLUTION FOR INFUSION CEFTRIAXONE (AS CEFTRIAXONE SODIUM) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What CEFTRIAXONE is and what it is used for 2. What you need to know before you are given CEFTRIAXONE 3. How CEFTRIAXONE is given 4. Possible side effects 5. How to store CEFTRIAXONE 6. Contents of the pack and other information 1. WHAT CEFTRIAXONE IS AND WHAT IT IS USED FOR CEFTRIAXONE is an antibiotic given to adults and children (including newborn babies). It works by killing bacteria that cause infections. It belongs to a group of medicines called cephalosporins_. _ CEFTRIAXONE is used to treat infections of • the brain (meningitis). • the lungs. • the middle ear. • the abdomen and abdominal wall (peritonitis). • the urinary tract and kidneys. • bones and joints. • the skin or soft tissues. • the blood. • the heart. It can be given: • to treat specific sexually transmitted infections (gonorrhoea and syphilis). • to treat patients with low white blood cell counts (neutropenia) who have f সম্পূর্ণ নথি পড়ুন
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT CEFTRIAXONE 500 mg Powder for Solution for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 0.596 g ceftriaxone sodium equivalent to 500 mg ceftriaxone. Sodium content per vial: 41.5 mg (equivalent to 1.8 mmol). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection. Almost white or slightly yellowish, crystalline powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS CEFTRIAXONE is indicated for the treatment of the following infections in adults and children including term neonates (from birth): • Bacterial Meningitis • Community acquired pneumonia • Hospital acquired pneumonia • Acute otitis media • Intra-abdominal infections • Complicated urinary tract infections (including pyelonephritis) • Infections of bones and joints • Complicated skin and soft tissue infections • Gonorrhoea • Syphilis • Bacterial endocarditis CEFTRIAXONE may be used: For treatment of acute exacerbations of chronic obstructive pulmonary disease in adults. For treatment of disseminated Lyme borreliosis (early (stage II) and late (stage III)) in adults and children including neonates from 15 days of age. For Pre-operative prophylaxis of surgical site infections. In the management of neutropenic patients with fever that is suspected to be due to a bacterial infection. In the treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. CEFTRIAXONE should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum (see section 4.4). Considerati সম্পূর্ণ নথি পড়ুন